Chemotherapy Combination Lengthens Survival in Stomach Cancer Patients
University of Texas MD Anderson Cancer CenterAdding docetaxel to the most commonly used combination chemotherapy improved tumor regression rate, delayed tumor growth and prolonged survival for patients with advanced stomach cancer, according to interim results of a Phase III international clinical trial.